School of Medicine
Showing 101-110 of 943 Results
-
Christopher Patrick Caridi
High-content Imaging Scientist, Innovative Medicines Accelerator (IMA)
Current Role at StanfordI am a High Content Imaging Scientist with Stanford's High-Throughput Screening Shared Facility (HTS @ the Nucleus), part of Sarafan ChEM-H and a shared resource of the Stanford Cancer Institute. Our mission is to give researchers access to fully automated high-throughput chemical, siRNA, cDNA, and high-content screening capabilities for both cell-based and enzyme/protein-based assays, accelerating the path from molecules to medicines.
My work centers on high-content imaging and phenotypic screening. I serve as a project manager for all cell-based screens and lead assay design, development, validation, and deployment, along with robotic programming and automation, data management, and co-decision-making on major instrumentation acquisitions. I partner with investigators across Stanford to translate their biological questions into robust, scalable, imaging-based screens.
The high-throughput screening (HTS) laboratory allows Stanford researchers and others to discover novel modulators of targets that otherwise would not be practical in industry. The center incorporates instrumentation (purchased with NCRR NIH Instrumentation grant numbers S10RR019513, S10RR026338, S10OD025004, and S10OD026899), databases, compound libraries, and personnel whose previous sole domains were in industry.
Among our instrumentation are a fully automated Molecular Devices ImageXpress Micro Confocal High-Content fluorescence microplate imager, with live cell, fluidics and phase contrast options. Specializing in image analysis, data acquisition, and assay development with a focus on multiplexed imaging. Here to assist all screening needs as well as targeted analyses, mechanism of action deconvolution and utilizing spatial biology to uncover novel mechanisms.
The HTS @ the Nucleus main screening lab is located in ChEM-H W008, the cell-based assay development lab is located in CCSR Room 0133-North Wing, between the Transgenic Mouse Facility, and the Stanford Genomics Facility. -
Eve Carlson
Clinical Professor, Psychiatry and Behavioral Sciences
BioEve Carlson is a Clinical Professor who focuses on fostering mental health after traumatic stress. She is a clinical psychologist and a researcher with the National Center for Posttraumatic Stress Disorder’s Dissemination and Training Division. Her primary interests are in measurement development and recovery after traumatic stress. She collaborates with faculty in Surgery (David Spain) and Medicine (Lisa Shieh) to study mental health of patients hospitalized after sudden, severe illness or injury, ethnoracial disparities in traumatic stress risks and responses, screening for risk of mental health problems, and preventive mental health care. Our research has found disparities in mental health responses in patients hospitalized after emergency care across ethnoracial groups that are explained by variance in risk factors, including social determinants of health. As PIs of a multi-center study funded by the National Institute on Minority Health and Health Disparities, Dr. Carlson and Dr. Spain and their collaborators have developed and validated a mental health risk screen for patients hospitalized after emergency care for acute illness or injury. Data from patients who identify as Asian American/Pacific Islander, Black, Latinx, multirace, and White were analyzed to inform screen development, and the screen accurately predicts later mental health outcomes within these ethnoracial groups. The Hospital Mental Health Risk Screen can be administered to patients hospitalized after emergency care to assess their risk for later mental health problems. Patients screening positive for mental health risk can be given preventive mental health care. Dr. Carlson has collaborated with Dr. Josef Ruzek and Dr. Matthew Cordova to create the TLC by recently admitted hospital patients reduces later mental health symptoms.
-
Robert W. Carlson
Professor of Medicine (Oncology and General Internal Medicine/Medical Informatics) at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsClinical investigations in breast cancer include institutional and NSABP studies of chemoprevention, adjuvant therapy, psychosocial interventions, treatment of metastatic disease, methods of decreasing anthracycline cardiotoxicity, and modulation of multidrug resistance. Research in meta-analysis includes the performance of meta-analysis in a wide variety of settings in cancer treatment by the international Meta-Analysis Group in Cancer.
-
Suzan L Carmichael, PhD, MS
Professor (Research) of Pediatrics (Neonatology), of Obstetrics & Gynecology (Maternal Fetal Medicine) and, by courtesy, of Epidemiology and Population Health
On Partial Leave from 2026-09-01 To 2026-10-31Current Research and Scholarly InterestsDr. Carmichael is a perinatal and nutritional epidemiologist and Professor of Pediatrics and Obstetrics and Gynecology at the Stanford University School of Medicine.
Her team is committed to finding ways to improve maternal and infant health outcomes and equity by leading research that identifies effective leverage points for change, from upstream 'macro' social and structural factors, to downstream clinical factors (eg, related to care and morbidities) through a collaborative research approach that integrates epidemiologic approaches with community engagement and systems thinking.
Exposure themes include social context, nutrition, care, environmental contaminants and genetics. Outcome themes include severe maternal morbidity, stillbirth, birth defects, and preterm delivery. She is particularly interested in understanding the intersectionality of these varied types of exposures and outcomes and how they interact to impact health and health disparities, for the mother-baby dyad.
Please see the team web-site for further information!
https://med.stanford.edu/carmichaellab.html
